Skip to main content
logo
Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China flag China · Delayed Price · Currency is CNY
4.750
+0.070 (1.50%)
Apr 10, 2026, 11:29 AM CST

SHA:603669 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
3,2933,6943,9884,1407,2046,150
Market Cap Growth
-4.10%-7.39%-3.66%-42.54%17.15%64.41%
Enterprise Value
3,3863,6263,7403,7206,5685,675
Last Close Price
4.685.255.535.749.848.30
PE Ratio
----109.3238.42
Forward PE
-16.6316.6316.6316.6316.63
PS Ratio
7.659.7320.2614.319.736.14
PB Ratio
4.484.804.283.654.944.16
P/TBV Ratio
5.155.524.854.065.414.47
P/FCF Ratio
----97.7794.81
P/OCF Ratio
----56.0748.50
EV/Sales Ratio
7.869.5519.0012.868.875.67
EV/EBITDA Ratio
----84.3940.47
EV/EBIT Ratio
----170.9655.28
EV/FCF Ratio
-20.42---89.1487.50
Debt / Equity Ratio
0.390.340.610.550.650.60
Debt / EBITDA Ratio
----11.646.33
Debt / FCF Ratio
----12.8813.68
Net Debt / Equity Ratio
0.13-0.03-0.18-0.30-0.42-0.58
Net Debt / EBITDA Ratio
-1.600.261.342.57-7.93-6.13
Net Debt / FCF Ratio
-0.560.182.763.16-8.37-13.25
Asset Turnover
0.360.260.110.130.280.43
Inventory Turnover
3.934.882.081.882.582.08
Quick Ratio
2.652.433.303.512.622.64
Current Ratio
3.112.683.633.742.762.79
Return on Equity (ROE)
-14.88%-15.38%-14.67%-15.10%4.49%11.46%
Return on Assets (ROA)
-3.94%-4.74%-6.11%-5.06%0.92%2.77%
Return on Invested Capital (ROIC)
-9.56%-14.46%-21.91%-21.70%4.91%13.92%
Return on Capital Employed (ROCE)
-7.50%-10.50%-12.30%-11.40%2.10%5.20%
Earnings Yield
-3.60%-3.54%-3.80%-4.73%0.92%2.60%
FCF Yield
-5.04%-3.24%-1.53%-2.64%1.02%1.05%
Dividend Yield
----1.02%2.41%
Payout Ratio
----241.58%70.59%
Buyback Yield / Dilution
-2.34%--0.17%-0.18%5.75%-5.87%
Total Shareholder Return
-2.34%--0.17%-0.18%6.76%-3.46%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.